Skip to content
Recall Observatory FDA recall evidence

Drug product

Hydralazine HCl Tablets, USP, 25mg, Rx only, 100 tablets per carton, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, Distributed by: MAJOR Pharmaceuticals, Livonia, MI, 48152, USA, NDC 0904-6441-61.

D-0045-2025

November 05, 2024

Class III

Product summary

Firm
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
Event
Event 95700
Status
Terminated
Classification
Class III
Quantity
25814 tablets
Official record key
drug-enforcement:D-0045-2025

Official wording

Reason: Failed Impurities/Degradation Specifications; during routine stability testing for impurities.

Code information: Lot#: T04888, Exp 11/2024; T04946, Exp 12/2024; T04970, Exp 07/2025

Distribution pattern: Nationwide in the US.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Impurities/Degradation Specifications